Dr. Saara Kaviany and Dr. Blachy J. Dávila Saldaña discuss treating HLH patients, focusing on controlling inflammation, hematopoietic stem cell transplants, and the importance of early recognition and targeted therapies for improved outcomes.

Dr. Ashish Kumar and Dr. Scott Canna discuss the challenges of diagnosing HLH, emphasizing the critical importance of a prompt diagnosis. They explore the complexities of HLH diagnosis, including the evolution of diagnostic criteria and the significance of genetic testing. The podcast highlights the limitations of current guidelines and the need for real-time resources to navigate diagnostic uncertainties.

Dr. Michelle Hermiston, a pediatric hematologist-oncologist, discusses the history and advances in understanding HLH, focusing on mechanisms of hyperinflammation, classification of HLH, and the importance of collaborative care in managing this complex disease.

In this episode of Investigating HLH, Adam Narloch, a Thought Leader Liaison at Sobi, speaks with Dr Michelle Hermiston to discuss the history of HLH and advances that have been made in understanding this rare disease. Dr Hermiston is a pediatric hematologist-oncologist, a bone marrow transplant specialist, and the director of the Pediatric Immunotherapy Program at UCSF Benioff Children’s Hospital. Join us as we start our journey into the world of HLH!Follow UsYouTube @Sobi-PharmaLinkedIn @SobiPresented by Sobi Inc.https://www.sobi.com/usa/en ©2023 Sobi, Inc. All rights reserved. NP-32204 12/23